A Look At Innovent Biologics (SEHK:1801) Valuation After Recent Share Price Momentum

Simply Wall St.03-30

Innovent Biologics (SEHK:1801) has drawn investor attention after recent share price moves, with the stock up 7.7% over the past day and 5.5% over the past week, inviting a closer look at its current ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2623313067?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","is_english":true,"pubTime":"2026-03-30 16:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2623313067","market":"hk","top_or_hot":-1,"title":"A Look At Innovent Biologics (SEHK:1801) Valuation After Recent Share Price Momentum","media":"Simply Wall St.","content":"<div>\n<p>Innovent Biologics (SEHK:1801) has drawn investor attention after recent share price moves, with the stock up 7.7% over the past day and 5.5% over the past week, inviting a closer look at its current ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1801/innovent-biologics-shares/news/a-look-at-innovent-biologics-sehk1801-valuation-after-recent\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At Innovent Biologics (SEHK:1801) Valuation After Recent Share Price Momentum</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At Innovent Biologics (SEHK:1801) Valuation After Recent Share Price Momentum\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-30 16:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1801/innovent-biologics-shares/news/a-look-at-innovent-biologics-sehk1801-valuation-after-recent><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Innovent Biologics (SEHK:1801) has drawn investor attention after recent share price moves, with the stock up 7.7% over the past day and 5.5% over the past week, inviting a closer look at its current ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1801/innovent-biologics-shares/news/a-look-at-innovent-biologics-sehk1801-valuation-after-recent\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2488822045.USD","symbol_name":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","start_time":0,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1801/innovent-biologics-shares/news/a-look-at-innovent-biologics-sehk1801-valuation-after-recent","article_id":"2623313067","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1801/innovent-biologics-shares/news/a-look-at-innovent-biologics-sehk1801-valuation-after-recent","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2623313067","pubTimestamp":1774858391,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Innovent Biologics (SEHK:1801) has drawn investor attention after recent share price moves, with the stock up 7.7% over the past day and 5.5% over the past week, inviting a closer look at its current valuation.\nSee our latest analysis for Innovent Biologics.\nThat 7.7% 1 day share price return and 8.5% year to date share price return sit against a 1 year total shareholder return of 85.1% and a 3 year total shareholder return of 143.2%, suggesting momentum has been building over time as the...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU2097828557.USD":"AZ EQUITY CHINA \"A\" (USD) ACC","LU0455707207.USD":"FIDELITY FUNDS  CHINA INNOVATION \"A\" (USD) INC","LU2097828805.USD":"AZ EQUITY CHINA \"A-AZ\" (USD) ACC","BK1161":"生物科技","BK1589":"北水核心资产","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","LU2097828631.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC","BK1583":"高瓴概念","01801":"信达生物","LU0502904849.HKD":"FIDELITY FUNDS  CHINA INNOVATION \"A\" (HKD) ACC","HK0000165453.HKD":"华夏精选大中华科技基金 A类港币","LU2097828714.EUR":"AZ EQUITY CHINA \"BAZ\" (EUR) ACC","LU2097828474.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC A"},"translate_title":"信达生物（SEHK：1801）近期股价势头后的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01801":0.9,"DCF":1},"content_text":"Innovent Biologics (SEHK:1801) has drawn investor attention after recent share price moves, with the stock up 7.7% over the past day and 5.5% over the past week, inviting a closer look at its current valuation. See our latest analysis for Innovent Biologics. That 7.7% 1 day share price return and 8.5% year to date share price return sit against a 1 year total shareholder return of 85.1% and a 3 year total shareholder return of 143.2%, suggesting momentum has been building over time as the market reassesses growth potential and risk. If this kind of move has your attention, it can be a useful moment to look beyond one name and see which other healthcare focused AI names are on investors’ radars through the 120 healthcare AI stocks With the shares now at HK$85.50, analyst targets and intrinsic estimates both suggest room between price and perceived value. The real question is whether this is a genuine opportunity or if the market is already baking in future growth. AdvertisementPreferred Price to Sales of 10x: Is it justified? On current numbers, Innovent Biologics is priced at a P/S of 10x, which screens as good value relative to both peers and a modelled fair level for the stock. The P/S multiple compares the company’s HK$13,041.52m of revenue to its HK$148.36b market value, giving a quick sense of how much investors are paying for each dollar of sales. For a biopharmaceutical group with a portfolio of commercial products and ongoing research and development, this kind of metric can be a useful cross check against more complex cash flow estimates. What stands out is how that 10x P/S stacks up. It sits below the estimated fair P/S of 11.5x, a level our fair ratio work suggests the market could move towards over time, and it is also below both the Hong Kong Biotechs industry average of 12.2x and the peer average of 27.5x. That combination points to a market price that is materially lower than what similar companies and the fair ratio model indicate for the same revenue base. Explore the SWS fair ratio for Innovent Biologics Result: Price-to-sales of 10x (UNDERVALUED) However, you still need to weigh the risks related to ongoing research outcomes and the heavy dependence on HK$12,069.48m of revenue from the PRC market. Find out about the key risks to this Innovent Biologics narrative. Another way to look at value The P/S of 10x points to good relative value, but the SWS DCF model paints an even stronger gap, with an estimated future cash flow value of HK$184.92 per share versus today’s HK$85.50. If both views lean cheap, how much of that gap are you comfortable ignoring? Look into how the SWS DCF model arrives at its fair value. 1801 Discounted Cash Flow as at Mar 2026Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Innovent Biologics for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 236 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity. Next Steps With all this in mind, sentiment around Innovent Biologics is clearly positive, but the real question is what you make of the story. If you want to move quickly and judge the potential for yourself, take a closer look at the 5 key rewards. Looking for more investment ideas? If Innovent has you thinking harder about your portfolio, this is the moment to widen your search and line up the next set of opportunities.  Spot potential value standouts early by scanning 236 high quality undervalued stocks before other investors catch on. Strengthen your income stream by reviewing companies in the 476 dividend fortresses that could complement growth focused holdings. Sleep easier at night by checking out the 267 resilient stocks with low risk scores to see which names align with a more conservative approach.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2623313067","isCrawlerRequest":true}